Evidence map›Paper›PMID 35011354›Full record

ArticleMolecules (Basel, Switzerland)2021

Design and Synthesis of New Thiophene/Thieno[2,3-

Elshaymaa I Elmongy, Nashwah G M Attallah, Najla Altwaijry, Manal Mubarak AlKahtani, Hanan Ali Henidi

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. 2-Alkyl-Substituted-4-Amino-Thieno[2,3-Molecules (Basel, Switzerland) · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Elshaymaa I ElmongyDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh P.O. Box 84428, Saudi Arabia.ORCID 0000-0003-1160-5040
Nashwah G M AttallahDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh P.O. Box 84428, Saudi Arabia.
Najla AltwaijryDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh P.O. Box 84428, Saudi Arabia.ORCID 0000-0001-6372-7141
Manal Mubarak AlKahtaniResearch Department, Health Sciences Research Center, Princess Nourah bint Abdulrahman University, Riyadh P.O. Box 84428, Saudi Arabia.
Hanan Ali HenidiResearch Department, Health Sciences Research Center, Princess Nourah bint Abdulrahman University, Riyadh P.O. Box 84428, Saudi Arabia.
Princess Nourah bint Abdulrahman University · SA

Funding

Deanship of Scientific Research at Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia, through the Research Funding Program Grant No# FRP-1440-21
6 · The paper itself

Abstract

This work describes the synthesis and anticancer activity against kinase enzymes of newly designed thiophene and thieno[2,3-

Indexed as

Antineoplastic AgentsApoptosisAutophagyCell Line, TumorCell ProliferationDose-Response Relationship, DrugDrug Screening Assays, Antitumorfms-Like Tyrosine Kinase 3HumansMolecular Docking SimulationProtein BindingProtein ConformationProtein Kinase InhibitorsPyrimidinesStructure-Activity RelationshipThiophenesAntineoplastic Agentsfms-Like Tyrosine Kinase 3Protein Kinase InhibitorsPyrimidinesThiophenescytotoxicityflow cytometryprotein kinasesthieno[2,3-d]pyrimidines

Identifiers

PMID35011354
PMCPMC8746632
OpenAlexW4200513997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.